Strosberg, J. R., Chan, J. A., Ryan, D. P., Meyerhardt, J. A., Fuchs, C. S., Abrams, T., . . . Kulke, M. H. (2013). A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors.
Citación estilo ChicagoStrosberg, J R., et al. A Multi-institutional, Phase II Open-label Study of Ganitumab (AMG 479) in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors. 2013.
Cita MLAStrosberg, J R., et al. A Multi-institutional, Phase II Open-label Study of Ganitumab (AMG 479) in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors. 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.